Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms

Surgery

Volumn 146, Issue 4, 2009, Pages 801-808

  Gauger, Paul G ^a   Doherty, Gerard M ^a   Broome, James T ^a   Miller, Barbra S ^a   Thompson, Norman W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; HEMOGLOBIN A1C; INSULIN; PROTON PUMP INHIBITOR;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER SURGERY; CARCINOID; CLINICAL ARTICLE; DIABETES MELLITUS; DUODENUM RESECTION; DUODENUM TUMOR; ENDOCRINE TUMOR; ENTEROCUTANEOUS FISTULA; FEMALE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTROJEJUNOSTOMY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGASTRINEMIA; INSULIN TREATMENT; INTERNAL HERNIA; INTESTINE SURGERY; LUNG EMBOLISM; LYMPH NODE METASTASIS; MALE; MULTIPLE CANCER; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS RESECTION; PANCREATICODUODENAL ENDOCRINE NEOPLASM; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTHESIS FAILURE; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; THYMUS CARCINOID; ULCER; URETER INJURY;

ADULT; DUODENAL NEOPLASMS; DUODENUM; FEMALE; GASTRINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; ZOLLINGER-ELLISON SYNDROME;

EID: 70349315095     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.06.038     Document Type: Article

References (20)

1. Burgess J.R., Greenaway T.M., and Shepherd J.J. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243 (1998) 465-470
2. Thompson N.W., Lloyd R.B., Nishiyama R.H., Vinik A.I., Strodel W.E., Allo M.D., et al. MEN I pancreas: a histological and immunohistological study. World J Surg 8 (1984) 561-574
3. Doherty G.M., Olson J.A., Frisella M.M., Lairmore T.C., Wells Jr. S.A., and Norton J.A. Lethality of multiple endocrine neoplasia type I. World J Surg 22 (1998) 581-586
4. Kouvaraki M.A., Shapiro S.E., Cote G.J., Lee J.E., Yao J.C., Waguespack S.G., et al. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 30 (2006) 643-653
5. Alexander H.R., Bartlett D.L., Venzon D.J., Libutti S.K., Doppman J.L., Fraker D.L., et al. Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome. Surgery 124 (1998) 1160-1166
6. Norton J.A., Fraker D.L., Alexander H.R., Venzon D.J., Doppman J.L., Serrano J., et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341 (1999) 635-644
7. Yu F., Venzon D.J., Serrano J., Goebel S.U., Doppman J.L., Gibril F., et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 17 (1999) 615-630
8. Akerstrom G., Hessman O., and Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN1. Langenbecks Arch Surg 386 (2002) 558-569
9. Gauger P.G., and Thompson N.W. Early surgical intervention and strategy in patients with multiple endocrine neoplasia Type 1. Best Pract Res Clin Endocrinol Metab 15 (2001) 213-223
10. Bartsch D.K., Fendrich V., Langer P., Celik I., Kann P.H., and Rothmund M. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 242 (2005) 757-766
11. Bartsch D.K., Langer P., and Rothmund M. Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1. Wien Klin Wochenschr 119 (2007) 602-608
12. Bartsch D.K., Langer P., Wild A., Schilling T., Celik I., Rothmund M., et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1. Surgery or surveillance?. Surgery 128 (2000) 958-966
13. Skogseid B., Oberg K., Akerstrom G., Eriksson B., Westlin J.E., Janson E.T., et al. Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?. World J Surg 22 (1998) 673-677
14. Skogseid B., Oberg K., Eriksson B., Juhlin C., Granberg D., Akerstrom G., et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1. World J Surg 20 (1996) 872-877
15. Thompson N.W. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 243 (1998) 495-500
16. Cadiot G., Vuagnat A., Doukhan I., Murat A., Bonnaud G., Delemer B., et al. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116 (1999) 286-293
17. Lowney J.K., Frisella M.M., Lairmore T.C., and Doherty G.M. Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: Correlation with primary tumor size. Surgery 124 (1998) 1043-1048
18. Hausman M.S., Thompson N.W., Gauger P.G., and Doherty G.M. The surgical management of MEN-1 pancreaticoduodenal neuroendocrine disease. Surgery 136 (2004) 1205-1211
19. Imamura M., Komoto I., Doi R., Onodera H., Kobayashi H., and Kawai Y. New pancreas-preserving total duodenectomy technique. World J Surg 29 (2005) 203-207
20. Gauger P.G., Scheiman J.M., Wamsteker E.J., Richards M.L., Doherty G.M., and Thompson N.W. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 90 (2003) 748-754